本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artivion

37.48
+0.08000.21%
盘后37.480.00000.00%16:20 EDT
成交量:20.18万
成交额:757.53万
市值:17.93亿
市盈率:178.48
高:38.11
开:37.61
低:37.41
收:37.40
52周最高:48.25
52周最低:21.97
股本:4,784.30万
流通股本:4,168.92万
量比:0.66
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):0.2100
每股收益(LYR):0.2100
净资产收益率:2.70%
总资产收益率:2.34%
市净率:4.00
市盈率(LYR):178.48

数据加载中...

公司资料

公司名字:
Artivion
交易所:
NYSE
成立时间:
1984
员工人数:
1800
公司地址:
1655 Roberts Boulevard NW,Kennesaw,Georgia,United States
邮编:
30144
电话:
传真:
- -
简介:
Artivion, Inc.于1984年在佛罗里达州注册成立,并于2022年1月1日将其注册州从佛罗里达州改为特拉华州。该公司是制造、加工和分销用于主动脉疾病患者心脏和血管手术的医疗器械和可植入人体组织的领导者。该公司有四个主要产品系列:主动脉支架移植物、On-X机械心脏瓣膜和相关手术产品、手术密封剂以及植入式心脏和血管人体组织。

董事

名称
职位
J. Patrick Mackin
President, Chief Executive Officer and Chairman of the Board
Anthony B. Semedo
Independent Director
Daniel J. Bevevino
Independent Director
Elizabeth A. Hoff
Independent Director
James W. Bullock
Independent Director
Jeffrey H. Burbank
Lead Independent Director
Jon W. Salveson
Independent Director
Marna P. Borgstrom
Independent Director
Thomas F. Ackerman
Independent Director

股东

名称
职位
J. Patrick Mackin
President, Chief Executive Officer and Chairman of the Board
Lance A. Berry
Chief Operating Officer, Chief Financial Officer and Treasurer
Jean F. Holloway
Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
John E. Davis
Senior Vice President, Global Sales and Marketing
Amy D. Horton
Vice President and Chief Accounting Officer
Andrew M. Green
Vice President, Regulatory Affairs
Florian Tyrs
Vice President, Global Operations
Matthew A. Getz
Vice President, Human Resources
Robert C. Thon
Vice President, Research and Development
Rochelle L. Maney
Vice President, Global Quality